SEC Form 4 · accession 0001104659-16-107418
Corvus Pharmaceuticals, Inc. · CRVS
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Steve E. Krognes
Director · 10% Owner
Period of report
Mar 22, 2016
Accepted (ET)
Mar 24, 2016 · 4:06 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001626971
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F1 | $15.00 | Mar 22, 2016 | A | 30,000 | A | — | Mar 22, 2026 | Common Stock | 30,000 | 30,000 | D |
Explanation of responses
- F1The underlying shares subject to the option vest and become exercisable as to one-third (1/3rd) of the shares subject to the option on each annual anniversary measured from January 20, 2016, subject to Reporting Person's continued service relationship with the Issuer on each such vesting date.